Amedisys Shares Climb 4.7% as UnitedHealth Merger Deadline Extended

Amedisys shares surge 4.7% pre-market. UnitedHealth merger faces DOJ antitrust scrutiny. Discover the impact on AMED stock.

A sleek and modern illustration of a stock market graph with upward trending lines, symbolizing Amed
Amedisys Shares Climb 4.7% as UnitedHealth Merger Deadline Extended

Amedisys Inc. shares rose by 4.7% pre-market as the merger with UnitedHealth faces DOJ scrutiny.

Source